1 / 45

Cost-Effectiveness in Medicine An Interactive Introduction

Cost-Effectiveness in Medicine An Interactive Introduction. Jan J. v. Busschbach, Ph.D. Erasmus MC Institute for Medical Psychology and Psychotherapy Viersprong Institute for studies on Personality Disorders Presentations can be found at: www.busschbach.nl. New cancer therapy.

baris
Download Presentation

Cost-Effectiveness in Medicine An Interactive Introduction

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Cost-Effectiveness in MedicineAn Interactive Introduction • Jan J. v. Busschbach, Ph.D. • Erasmus MC • Institute for Medical Psychology and Psychotherapy • Viersprong Institute for studies on Personality Disorders • Presentations can be found at: • www.busschbach.nl

  2. New cancer therapy Symptoms Drug X Drug Y Survival days 300 400 Days sick of chemotherapy 10 150 Days sick of disease 100 30 TWiST 190 220

  3. Time Without Symptoms of disease and subjective Toxic effects of treatment • TWiST • Developed by Richard Gelber (statistician) • In search for a typical “cancer” problem • Often prolonged life but also a reductions in quality of life • At the beginning (side effects) • At the end • Only count the days without symptoms of disease and subjective toxic effects of the treatment

  4. TWiST in cancer therapy

  5. Fit new therapy in fixed budget • 50 patients each year (per hospital) • Drug x: 50 x euro 1.750 = euro 87.500 • Drug y: 50 x euro 2.000 = euro 100.000 • Drug budget for x or y = euro 50.000 • Number of patient • Drug x: euro 50.000 / 1.750 = 28.5 patients • Drug y: euro 50.000 / 2.000 = 25.0 patients • Survival in days • Drug x: 28.5 patients x 300 days = 8.550 days • Drug y: 25.0 patients x 400 days = 10.000 days • Survival in TWiST • Drug x: 28.5 patients x 190 TWiST = 5.415 days • Drug y: 25.0 patients x 220 TWiST = 5.500 days

  6. 0.0 Quality of life 1.0 TWiST: ignores differences in quality of life • TWiST • Healthy = 1 • Sick (dead) = 0 • There is more to life than sick/health • Make intermediate values • Q-TWiST • Quality of life adjusted adjusted TWiST • How to scale quality of life?

  7. Quality of life • “…. Health is physical, mental and social well-being and not merely the absence of disease or infirmity...” • World Health Organization, 1947 • Extending health to well-being: Quality of life • What is the definition of quality of life?

  8. Definitions of Quality of Life • Quality of life is the degree of need and satisfaction within the physical, psychological, social, activity, material and structural area (Hörnquist, 1982). • Quality of life is the subjective evaluation of good and satisfactory character of life as a whole (De Haes, 1988). • Health related quality of life is the subjective experiences or preferences expressed by an individual, or members of a particular group of persons, in relation to specified aspects of health status that are meaningful, in definable ways, for that individual or group (Till, 1992). • Quality of life is a state of well-being which is a composite of two components: 1) the ability to perform everyday activities which reflects physical psychological, and social well-being and 2) patient satisfaction with levels of functioning and the control of disease and/or treatment related symptoms (Gotay et al., 1992). • An individual’s perception of their position in life in the context of the culture and values systems in which they live and in relation to their goals, expectations, standards and concerns (WHO Quality of life Groups, 1993).

  9. No clear definition because:… • Many possible definitions • Researchers are free to choose • The notion of measuring the quality of life could include the measurement of practically anything of interest to anybody. And, no doubt, everybody could find arguments supporting the selection of whichever set of indicators to be his choice • (Andrews & Withy, 1976, page 6) • Different origins of research • Clinical decision making:… • does the patient benefit from the treatment? • Epidemiology (public health):… • what is the morbidity of the population? • Health economics:… • is it worth the money?

  10. Common items in definitions: • It is not the doctor who reports • Quality of life is subjective…. • “Given its inherently subjective nature, consensus was quickly reached that quality of life ratings should, whenever possible, be elicited directly from patients themselves. “ (Aaronson, in B Spilker (Ed): Quality of life and Pharmacoeconomics in Clinical Trails, 1996, page 180)

  11. Common items in definitions: • Health related • Multidimensional • Physical, psychological, social • Questionnaires • Standardize questions and response • Reproducible results: sciences • Quantify subjectivity • Operational defined • Like IQ and temperature.

  12. How to measure quality of life form a clinical point of view? • Choose items • Are you able to walk one kilometer ? • Do you feel depressed ? • Choose response mode • Binary yes / no • Multiple (Likert) yes / at bid / hardly / no • Continuous (Visual Analogue Scale) Always ————X—— Never • Combine items to dimensions of quality of life • Sum up the items belonging to one dimension • Rescale sum on a scale from 0 to 100

  13. SF-36

  14. SF-36

  15. Multidimensionality in outcomes in health care • What if outcome conflict… • e.g: better mobility, but worse roll emotional • On has to weight or combine outcomes • What if some patients dies? • Cancer therapy • Better quality of life, but higher mortality • Weight quality of life with mortality

  16. Value a health state • Wheelchair • Some problems in walking about • Some problems washing or dressing • Some problems with performing usual activities • Some pain or discomfort • No psychosocial problems

  17. Normal health X Dead Visual Analogue Scale • VAS • Also called “category scaling” • From psychological research • “How is your quality of life?” • “X” marks the spot • Rescale to [0..1] • Different anchor point possible: • Normal health (1.0) versus dead (0.0) • Best imaginable health versusworse imaginable health

  18. EuroQol EQ-5D • MOBILITY • I have no problems in walking about • I have some problems in walking about • I am confined to bed • SELF-CARE • I have no problems with self-care • I have some problems washing or dressing myself • I am unable to wash or dress myself • USUAL ACTIVITIES (e.g. work, study, housework family or leisure activities) • I have no problems with performing my usual activities • I have some problems with performing my usual activities • I am unable to perform my usual activities • PAIN/DISCOMFORT • I have no pain or discomfort • I have moderate pain or discomfort • I have extreme pain or discomfort • ANXIETY/DEPRESSION • I am not anxious or depressed • I am moderately anxious or depressed • I am extremely anxious or depressed

  19. Ratio scale in QoL • If we want to weight dimensions of QoL…. • Values should be (at least) on interval scale • Is it possible? • My Qol is today twice as good as yesterday • Her IQ is twice as high… • This painting is twice as beautiful as… • His depression is twice as… • My lecture is twice as…. • Is a VAS ratio or interval?

  20. Uni-dimensional value • Ratio or interval scale • Difference 0.00 and 0.80 must be 8 time higher than 0.10 • Two methods have these pretensions • Time trade-off • Standard gamble

  21. Time Trade-Off • TTO • Wheelchair • With a life expectancy: 50 years • How many years would you trade-off for a cure? • Max. trade-off is 10 years • QALY(wheel) = QALY(healthy) • Y * V(wheel) = Y * V(healthy) • 50 V(wheel) = 40 * 1 • V(wheel) = .8

  22. Standard Gamble • SG • Wheelchair • Life expectancy is not important here • How much are risk on death are you prepared to take for a cure? • Max. risk is 20% • wheels = (100%-20%) life on feet • V(Wheels) = 80% or .8

  23. 0.0 Quality of life 1.0 TWiST: ignores differences in quality of life • TWiST • Healthy = 1 • Sick (dead) = 0 • There is more to life than sick/health • Make intermediate values • Q-TWiST • Quality of life adjusted adjusted TWiST • How to scale quality of life?

  24. In health economics: Q-TWiST = QALY • Count life years • Value (V) quality of life (Q) • V(Q) = [0..1] • 1 = Healthy • 0 = Dead • One dimension • Adjusted life years (Y) for value quality of life • QALY = Y * V(Q) • Y: numbers of life years • Q: health state • V(Q): the value of health state Q • Also called “utility analysis”

  25. Which health care program is the most cost-effective? • A new wheelchair for elderly (iBOT) • Special post natal care

  26. Which health care program is the most cost-effective? • A new wheelchair for elderly (iBOT) • Increases quality of life = 0.1 • 10 years benefit • Extra costs: $ 3,000 per life year • QALY = Y x V(Q) = 10 x 0.1 = 1 QALY • Costs are 10 x $3,000 = $30,000 • Cost/QALY = 30,000/QALY • Special post natal care • Quality of life = 0.8 • 35 year • Costs are $250,000 • QALY = 35 x 0.8 = 28 QALY • Cost/QALY = 8,929/QALY

  27. QALY league table

  28. Egalitarian Concerns:Burden of disease 1.0 Utility of Health 0.0 A B C

  29. Implications shifting threshold • QALY are weighted • Weighted QALYs are maximized • Health is no longer the only thing maximized • Health status population will drop • Differences in health will drop • Egalitarian consideration are incorporated • Burden of disease becomes a criteria • Equity

  30. CE-ratio by equity

  31. Conclusion • Cost effectiveness in medicine can be measured • Burden of disease is also a criterion

  32. The YAVIS patient in psychology • YAVIS • Young, Attractive, Verbal, Intelligent and Successful • Young, Attractive, Verbal, Intelligent, and Successful • Young, Attractive, Verbal, Insightful, and Successful • Young, Attractive, Vital, Intelligent, and Successful • Young, Affluent, Verbal, Insured, and Single • Is there a ‘need’ for treatment? • Is the QoL low?

  33. Personality disorder is not YAVIS

  34. Patient values or values from the general public

  35. The clinical perspective • Quality of life is subjective….. • “Given its inherently subjective nature, consensus was quickly reached that quality of life ratings should, whenever possible, be elicited directly from patients themselves. “ (Aaronson, in B Spilker (Ed): Quality of life and Pharmacoeconomics in Clinical Trails, 1996, page 180) • The patient values count in clinical quality of life research

  36. Healthy Death Coping (response shift) • Stensman • Scan J Rehab Med 1985;17:87-99. • Scores on a visual analogue scale • 36 subjects in a wheelchair • 36 normal matched controls • Mean score • Wheelchair: 8.0 • Health controls: 8.3

  37. The economic perspective • In a normal market: the consumer values count • The patient seems to be the consumer • Thus the values of the patients…. • If indeed health care is a normal market… • But is it….?

  38. Health care is not a normal market • Supply induced demands • Government control • Financial support (egalitarian structure) • Patient  Consumer • The patient does not pay • Consumer = General public • Potential patients are paying • Health care is an insurance market • A compulsory insurance market

  39. Health care is an insurance market • Values of benefit in health care have to be judged from a insurance perspective • Who values should be used the insurance perspective?

  40. Who determines the payments of unemployment insurance? • Civil servant • Knowledge: professional • But suspected for strategical answers • more money, less problems • identify with unemployed persons • The unemployed persons themselves • Knowledge: specific • But suspected for strategical answers • General public (politicians) • Knowledge: experience • Payers

  41. Who’s values (of quality of life) should count in the health insurance? • Doctors • Knowledge: professional • But suspected for strategical answers • See only selection of patient • Identification with own patient • Patients • Knowledge: disease specific • But suspected for strategical answers • But coping • General public • Knowledge: experience • Payers • Like costs: the societal perspective

  42. The general public should be informed… • Valuing without knowledge makes no sense • Thyroid Eye Disease • Give description of the disease A patient with bilateral thyroid eye disease with upper lid retraction and exophthalmos.

  43. …or use validated questionnaires MOBILITY • I have no problems in walking about • I have some problems in walking about • I am confined to bed SELF-CARE • I have no problems with self-care • I have some problems washing or dressing myself • I am unable to wash or dress myself USUAL ACTIVITIES (e.g. work, study, housework family or leisure activities) • I have no problems with performing my usual activities • I have some problems with performing my usual activities • I am unable to perform my usual activities PAIN/DISCOMFORT • I have no pain or discomfort • I have moderate pain or discomfort • I have extreme pain or discomfort ANXIETY/DEPRESSION • I am not anxious or depressed • I am moderately anxious or depressed • I am extremely anxious or depressed

  44. Describe health states Have values from the general public Rosser Matrix QWB 15D HUI Mark 2 HUI Mark 3 EuroQol EQ-5D Validated Questionnaires in the societal perspective

  45. Different perspective belong to different research questions • Health economics • Societal perspective • General public • Medical decision making • Patients perspective • Epidemiology • Doctors perspective • Global Burden of Disease

More Related